★ Sign in to follow
AP

Annexin Pharmaceuticals AB Stock: price and insider trades · Sweden

ISIN SE0013748894SE·

No insider purchase over the last 90 days. The latest, by Carl-Fredrik Lindner, was filed 18 Dec 2023.

Annexin Pharmaceuticals AB: what insiders have been doing

Annexin Pharmaceuticals AB is a listed company. Filings by its managers are published through Finansinspektionen. No insider at Annexin Pharmaceuticals AB has published a filing in the past twelve months. The most recent one dates from 20 December 2023.

Our records for Annexin Pharmaceuticals AB go back to 2020, with 15 purchases and no sales on the open market in total.

Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
19
Thresholds
n/a
Buy Volume
€96,262
15 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 20 December 2023
Declarations19 total
  • ◆
    Uli Hacksell
    StyrelseordförandeExecutives
    22,000 SEK0FI-SE
    110,000 shares@ SEK 0.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0021148707FI:csv-e1ba4ea752fac115b76f
  • ▲
    Carl-Fredrik Lindner
    StyrelseledamotExecutives
    100,001 SEK0FI-SE
    500,005 shares@ SEK 0.20100.0% of flowTeckningsrätt/UniträttISIN SE0021148699FI:csv-fed0d4d2c027a826f4b6
    Canonical exit: 14 Mar 2024 (T+90)
  • ▲
    Nils Anders Haegerstrand
    VDExecutives
    500,000 SEK0FI-SE
    1,250,000 shares@ SEK 0.4079.1% of flowTeckningsoptionFI:csv-93f1c800b86437fd313e
    Canonical exit: 15 Oct 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    94,303 SEK0FI-SE
    235,758 shares@ SEK 0.4056.1% of flowTeckningsoptionFI:csv-7bf48d427ee67cd9720d
    Canonical exit: 15 Oct 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    12,000 SEK0FI-SE
    10,000 shares@ SEK 1.206.5% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-c2752bee1889d219bd1e
    Canonical exit: 4 Jun 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    32,500 SEK0FI-SE
    25,000 shares@ SEK 1.3019.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-96edcff076f63dade40a
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    13,000 SEK0FI-SE
    10,000 shares@ SEK 1.307.6% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-90ba01329c3467e13472
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    2,972 SEK0FI-SE
    2,286 shares@ SEK 1.301.7% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-e1d01cde8d9dc3234c17
    Canonical exit: 3 Jun 2020 (T+90)
  • ●
    Johan Frostegård
    Styrelseledamot/suppleantExecutives
    2M SEK0FI-SE
    1,404,972 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-2624c95757eb4fa89f6d
  • ●
    Anna Frostegård
    Chief Medical and Scientific OfficerExecutives
    2M SEK0FI-SE
    1,404,972 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-bf8a6e82fedfad0f55f8
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    23,400 SEK0FI-SE
    18,000 shares@ SEK 1.3013.6% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-611e582e18d54010bd3f
    Canonical exit: 1 Jun 2020 (T+90)
  • ▲
    Henrik Palm
    Ekonomi/finanschefExecutives
    3,420 SEK0FI-SE
    2,714 shares@ SEK 1.262.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-1d3a573db48c01aaf0e4
    Canonical exit: 1 Jun 2020 (T+90)
  • ●
    Susan Suchdev
    COOExecutives
    69,007 SEK0FI-SE
    60,006 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-5549110c8e56fb9520be
  • ▲
    Nils Anders Haegerstrand
    VDExecutives
    3,153 SEK0FI-SE
    2,407 shares@ SEK 1.310.5% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-22ad84e2f82856bc35f0
    Canonical exit: 27 May 2020 (T+90)
  • ▲
    Nils Anders Haegerstrand
    VDExecutives
    28,500 SEK0FI-SE
    22,093 shares@ SEK 1.294.4% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-952fa4b6221fab0a5598
    Canonical exit: 27 May 2020 (T+90)
  • ▲
    Nils Anders Haegerstrand
    VDExecutives
    38,400 SEK0FI-SE
    30,000 shares@ SEK 1.286.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-a1ccc9b38822007960ed
    Canonical exit: 26 May 2020 (T+90)
  • ▲
    Nils Anders Haegerstrand
    VDExecutives
    64,500 SEK0FI-SE
    50,000 shares@ SEK 1.2910.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-b2762c462d024b08e76d
    Canonical exit: 26 May 2020 (T+90)
  • ▲
    Lena Torlegård
    Styrelseledamot/suppleantExecutives
    62,895 SEK0FI-SE
    50,000 shares@ SEK 1.257964.7% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-3d5c77379bec90d5bea6
    Canonical exit: 25 May 2020 (T+90)
  • ▲
    Lena Torlegård
    Styrelseledamot/suppleantExecutives
    34,364 SEK0FI-SE
    27,273 shares@ SEK 1.2635.3% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-6815ed255533de3bb0d8
    Canonical exit: 25 May 2020 (T+90)

19 of 19 declarations

About Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB is a pharmaceutical company focused on developing treatments for inflammatory diseases and cardiovascular disorders. It is listed on the XSTO exchange.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.